Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies
J Zhang, Y Zhang, J Wang, Y **a, J Zhang… - Signal transduction and …, 2024 - nature.com
Alzheimer's disease (AD) stands as the predominant form of dementia, presenting significant
and escalating global challenges. Its etiology is intricate and diverse, stemming from a …
and escalating global challenges. Its etiology is intricate and diverse, stemming from a …
Application of marine natural products against Alzheimer's disease: past, present and future
D Hu, Y **, X Hou, Y Zhu, D Chen, J Tai, Q Chen… - Marine Drugs, 2023 - mdpi.com
Alzheimer's disease (AD), a neurodegenerative disease, is one of the most intractable
illnesses which affects the elderly. Clinically manifested as various impairments in memory …
illnesses which affects the elderly. Clinically manifested as various impairments in memory …
[HTML][HTML] Therapeutic potential of targeting mitochondria for Alzheimer's disease treatment
Alzheimer's disease (AD), a chronic and progressive neurodegenerative disease, is
characterized by memory and cognitive impairment and by the accumulation in the brain of …
characterized by memory and cognitive impairment and by the accumulation in the brain of …
Natural alkaloids as multi-target compounds towards factors implicated in Alzheimer's disease
R Vrabec, G Blunden, L Cahlíková - International Journal of Molecular …, 2023 - mdpi.com
Alzheimer's disease (AD) is the most common cause of dementia in elderly people;
currently, there is no efficient treatment. Considering the increase in life expectancy …
currently, there is no efficient treatment. Considering the increase in life expectancy …
Molecular interactions, binding stability, and synergistic inhibition on Acetylcholinesterase activity of Safranin O in combination with Quercetin and Gallic acid: In vitro …
The clinical management of multifactorial diseases, especially in neurodegenerative
disorders, requires the identification of potent synergistic interactions between therapeutic …
disorders, requires the identification of potent synergistic interactions between therapeutic …
Acai Berry (Euterpe sp.) Extracts Are Neuroprotective against L-Glutamate-Induced Toxicity by Limiting Mitochondrial Dysfunction and Cellular Redox Stress
MN ALNasser, AM AlSaadi, A Whitby, DH Kim… - Life, 2023 - mdpi.com
Aberrant accumulation of the neurotransmitter L-glutamate (L-Glu) has been implicated as a
mechanism of neurodegeneration, and the release of L-Glu after stroke onset leads to a …
mechanism of neurodegeneration, and the release of L-Glu after stroke onset leads to a …
Angelica gigas: Signature Compounds, In Vivo Anticancer, Analgesic, Neuroprotective and Other Activities, and the Clinical Translation Challenges
Angelica gigas Nakai (AGN) root is a medicinal herbal widely used in traditional medicine in
Korea. AGN root ethanolic extract dietary supplements are marketed in the United States for …
Korea. AGN root ethanolic extract dietary supplements are marketed in the United States for …
In silico design of dual-binding site anti-cholinesterase phytochemical heterodimers as treatment options for Alzheimer's disease
The number of patients with neurodegenerative diseases, particularly Alzheimer's disease
(AD), continues to grow yearly. Cholinesterase inhibitors (ChEIs) represent the first-line …
(AD), continues to grow yearly. Cholinesterase inhibitors (ChEIs) represent the first-line …
[HTML][HTML] A Preliminary Assessment of the Nutraceutical Potential of Acai Berry (Euterpe sp.) as a Potential Natural Treatment for Alzheimer's Disease
Alzheimer's disease (AD) is characterised by progressive neuronal atrophy and the loss of
neuronal function as a consequence of multiple pathomechanisms. Current AD treatments …
neuronal function as a consequence of multiple pathomechanisms. Current AD treatments …
Recent advances in potential enzymes and their therapeutic inhibitors for the treatment of Alzheimer's disease
Abstract Alzheimer's disease (AD), a chronic neurodegenerative disease, is clinically
characterized by loss of memory and learning ability among other neurological deficits …
characterized by loss of memory and learning ability among other neurological deficits …